ClinicalTrials.Veeva

Menu

Effect of a Health Pathway for People With Persistent Symptoms Covid-19 (SPACO+)

C

Centre Hospitalier Universitaire de Saint Etienne

Status

Enrolling

Conditions

COVID-19

Treatments

Other: usual care and follow-up by a nurse
Other: Personalized Multifactorial Intervention (IMP)

Study type

Interventional

Funder types

Other

Identifiers

NCT05787366
22CH550
2020-A00982-37 (Other Identifier)

Details and patient eligibility

About

People with persistent symptoms of covid-19 have increased needs for needs for management of their overall health (physical, psychological and social). Persistent covid-19 symptoms have a negative impact on quality of life. By proposing a follow-up and an intervention on the reduction of these symptoms, the symptoms, the study will improve quality of life.

Enrollment

400 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria

  • Persons who have been infected with Covid-19.
  • Person with persistent clinical signs of Covid-19 for more than 12 weeks, referred by one of the partner structures of the project. The persistent signs of Covid-19 are: fatigue which can be severe, neurological disorders neurological disorders (cognitive, sensory, headaches), cardio-thoracic disorders (pain and chest tightness, tachycardia, dyspnea, cough) and disorders of smell and taste. Pain, digestive disorders and skin disorders are also common.
  • Person who has agreed to participate and has given informed consent to participate in the study

Exclusion Criteria:

  • Refused to participate in the study
  • Person under legal protection
  • Person with severe cognitive impairment

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

400 participants in 2 patient groups

Usual care
Other group
Description:
usual care and follow-up by a nurse: control group receiving conventional management, i.e. referral to a specialist(s) according to symptoms, as well as nursing follow-up.
Treatment:
Other: usual care and follow-up by a nurse
Intervention group
Experimental group
Description:
usual care and Personalized Multifactorial Intervention: group benefiting from the Personalized Multifactorial Intervention coordinated by a nurse
Treatment:
Other: Personalized Multifactorial Intervention (IMP)

Trial contacts and locations

3

Loading...

Central trial contact

Caroline DUPRE, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems